{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:10:32Z","timestamp":1791864632779,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.msec.2019.01.036","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T22:28:26Z","timestamp":1547159306000},"page":"843-860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["Chitosan grafted-poly(ethylene glycol) methacrylate nanoparticles as carrier for controlled release of bevacizumab"],"prefix":"10.1016","volume":"98","author":[{"given":"Corina-Lenu\u021ba","family":"Savin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4929-0830","authenticated-orcid":false,"given":"Marcel","family":"Popa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Delaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Costuleanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u0103nu\u021b","family":"Costin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u0103t\u0103lina Ani\u0219oara","family":"Peptu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.msec.2019.01.036_bb0005","first-page":"961","article-title":"Drug delivery for posterior segment eye disease","volume":"41","author":"Geroski","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"42","key":"10.1016\/j.msec.2019.01.036_bb0010","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.2174\/1381612821666151027151847","article-title":"Modern drug delivery systems for targeting the posterior segment of the eye","volume":"21","author":"Peptu","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.msec.2019.01.036_bb0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejpb.2016.10.009","article-title":"Lipid nanoparticles (SLN, NLC): overcoming the anatomical and physiological barriers of the eye \u2013 part I \u2013 barriers and determining factors in ocular delivery","volume":"110","author":"S\u00e1nchez-L\u00f3pez","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.msec.2019.01.036_bb0020","first-page":"232","article-title":"Novel approach for management of age-related macular degeneration antiangiogenic therapy and retinal regenerative therapy","volume":"111","author":"Tamaki","year":"2007","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"1","key":"10.1016\/j.msec.2019.01.036_bb0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0039-6257(92)90003-C","article-title":"Systemic antiviral drugs used in ophthalmology","volume":"37","author":"Teich","year":"1992","journal-title":"Surv. Ophthalmol."},{"issue":"5","key":"10.1016\/j.msec.2019.01.036_bb0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.msec.2019.01.036_bb0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1634\/theoncologist.12-6-713","article-title":"FDA drug approval summary: bevacizumab (Avastin\u00ae) plus carboplatin and paclitaxel as first-line treatment of advanced\/metastatic recurrent nonsquamous non-small cell lung cancer","volume":"12","author":"Cohen","year":"2007","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.msec.2019.01.036_bb0040","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1634\/theoncologist.2009-0121","article-title":"FDA drug approval summary: bevacizumab (Avastin\u00ae) as treatment of recurrent glioblastoma multiforme","volume":"14","author":"Cohen","year":"2009","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.msec.2019.01.036_bb0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00006982-200603000-00001","article-title":"Testing intravitreal toxicity of bevacizumab (Avastin)","volume":"26","author":"Manzano","year":"2006","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.msec.2019.01.036_bb0050","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00006982-200603000-00002","article-title":"Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin)","volume":"26","author":"Shahar","year":"2006","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.msec.2019.01.036_bb0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajo.2006.03.058","article-title":"Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model","volume":"142","author":"Bakri","year":"2006","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.msec.2019.01.036_bb0060","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/bjo.2006.094995","article-title":"Effects of bevacizumab on retinal function in isolated vertebrate retina","volume":"90","author":"L\u00fcke","year":"2006","journal-title":"Br. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.msec.2019.01.036_bb0065","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/IAE.0b013e3181a2f42a","article-title":"Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (Avastin) for intravitreal administration","volume":"29","author":"Abrishami","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.msec.2019.01.036_bb0070","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ijbiomac.2014.10.052","article-title":"Review chitosan-based nanoparticles for tumor-targeted drug delivery","volume":"72","author":"Prabaharan","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.msec.2019.01.036_bb0075","series-title":"American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition","article-title":"Preparation and characterization of bevacizumab (Avastin) nanoparticles for the treatment of age related macular degeneration","author":"Hao","year":"2009"},{"issue":"3","key":"10.1016\/j.msec.2019.01.036_bb0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/jop.2010.0158","article-title":"Comparison of long acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model","volume":"27","author":"Pan","year":"2011","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.msec.2019.01.036_bb0085","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/1874364101206010054","article-title":"Controlled release of bevacizumab through nanospheres for extended treatment of age-related macular degeneration","volume":"6","author":"Li","year":"2012","journal-title":"Open Ophthalmol. J."},{"key":"10.1016\/j.msec.2019.01.036_bb0090","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2014.05.031","article-title":"Nanotherapy for posterior eye diseases","volume":"193","author":"Kaur","year":"2014","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.msec.2019.01.036_bb0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2006.10.004","article-title":"Phase transition water-in-oil microemulsions as ocular drug delivery systems: in vitro and in vivo evaluation","volume":"328","author":"Chan","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.msec.2019.01.036_bb0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cis.2004.02.003","article-title":"Preparation of metal nanoparticles in water-in-oil (w\/o) microemulsions","volume":"110","author":"Capek","year":"2004","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.msec.2019.01.036_bb0105","series-title":"Biomass as Renewable Raw Materials for Bioproducts","first-page":"372","article-title":"Chemically modified polysaccharides with applications in nanomedicine","author":"Desbrieres","year":"2018"},{"issue":"11","key":"10.1016\/j.msec.2019.01.036_bb0110","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.cclet.2014.06.027","article-title":"Preparation and characterization of mPEG grafted chitosan micelles as 5-fluorouracil carriers for effective anti-tumor activity","volume":"25","author":"Fu","year":"2014","journal-title":"Chin. Chem. Lett."},{"issue":"1\u20132","key":"10.1016\/j.msec.2019.01.036_bb0115","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijpharm.2012.04.004","article-title":"Chitosan-g-PEG nanoparticles ionically crosslinked with poly(glutamic acid) and tripolyphosphate as protein delivery systems","volume":"430","author":"Papadimitriou","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.msec.2019.01.036_bb0120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.progpolymsci.2011.10.001","article-title":"Review PEGylated chitosan derivatives: synthesis, characterizations and pharmaceutical applications","volume":"37","author":"Casettari","year":"2012","journal-title":"Prog. Polym. Sci."},{"issue":"2","key":"10.1016\/j.msec.2019.01.036_bb0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.colsurfb.2007.07.012","article-title":"Self aggregated nanoparticles from methoxy poly(ethylene glycol)-modified chitosan: synthesis; characterization; aggregation and methotrexate release in vitro","volume":"61","author":"Yang","year":"2008","journal-title":"Colloids Surf. B"},{"issue":"21","key":"10.1016\/j.msec.2019.01.036_bb0130","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1016\/S0032-3861(97)10020-9","article-title":"Aggregation phenomenon of PEG grafted chitosan in aqueous solution","volume":"39","author":"Ouchi","year":"1998","journal-title":"Polymer"},{"issue":"3","key":"10.1016\/j.msec.2019.01.036_bb0135","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejpb.2007.08.009","article-title":"Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles","volume":"68","author":"Zhang","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"12","key":"10.1016\/j.msec.2019.01.036_bb0140","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s10856-008-3500-8","article-title":"PEG-grafted chitosan nanoparticles as an injectable carrier for sustained protein release","volume":"19","author":"Zhang","year":"2008","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"12","key":"10.1016\/j.msec.2019.01.036_bb0145","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1163\/156856207794761943","article-title":"Investigation on the properties of methoxy poly(ethylene glycol)\/chitosan graft co-polymers","volume":"18","author":"Deng","year":"2007","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"6","key":"10.1016\/j.msec.2019.01.036_bb0150","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/bc050217o","article-title":"Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26","volume":"16","author":"Aktas","year":"2005","journal-title":"Bioconjug. Chem."},{"issue":"7\u20138","key":"10.1016\/j.msec.2019.01.036_bb0155","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1163\/156856209X444330","article-title":"In vivo validation of biological responses of bfgf released from microspheres formulated by blending poly-lactide-co-glycolide and poly(ethylene glycol)-grafted-chitosan in hamster cheek pouch microcirculatory models","volume":"20","author":"Falabella","year":"2009","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"1","key":"10.1016\/j.msec.2019.01.036_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11095-008-9713-1","article-title":"Intracellular delivery of heparin complexed with chitosan-g-poly(ethylene glycol) for inducing apoptosis","volume":"26","author":"Bae","year":"2009","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.msec.2019.01.036_bb0165","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijbiomac.2009.08.007","article-title":"Photo-polymeriable chitosan derivative prepared by Michael reaction of chitosan and polyethylene glycol diacrylate (PEGDA)","volume":"45","author":"Ma","year":"2009","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.msec.2019.01.036_bb0170","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/0883911509350262","article-title":"Double cross-linked chitosan\u2013gelatin particulate systems for ophthalmic applications","volume":"25","author":"Peptu","year":"2010","journal-title":"J. Bioact. Compat. Polym."},{"key":"10.1016\/j.msec.2019.01.036_bb0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijbiomac.2016.07.058","article-title":"New hybrid magnetic nanoparticles based on chitosan-maltose derivative for antitumor drug delivery","volume":"92","author":"Alupei","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"1\u20132","key":"10.1016\/j.msec.2019.01.036_bb0180","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijpharm.2012.06.029","article-title":"Double crosslinked interpenetrated network in nanoparticle form for drug targeting\u2013preparation, characterization and biodistribution studies","volume":"436","author":"Jatariu (Cadinoiu)","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2019.01.036_bb0185","first-page":"11","article-title":"Investigations on agglomeration and haemocompatibility of vitamin E TPGS surface modified berberine chloride nanoparticles","author":"Vuddanda","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.msec.2019.01.036_bb0190","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0021-5155(99)00092-1","article-title":"Experimental uveitis induced by intravitreal or intravenous lipoteichoic acid in rabbits","volume":"43","author":"Chen","year":"1999","journal-title":"Jpn. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.msec.2019.01.036_bb0195","first-page":"245","article-title":"The use of animal models in the study of diabetes mellitus","volume":"23","author":"Chatzigeorgiou","year":"2009","journal-title":"In Vivo"},{"issue":"2","key":"10.1016\/j.msec.2019.01.036_bb0200","first-page":"232","article-title":"Establishing an experimental rat model of photodynamically-induced retinal vein occlusion using erythrosin B","volume":"7","author":"Chen","year":"2014","journal-title":"Int. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.msec.2019.01.036_bb0205","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10456-013-9398-x","article-title":"In vitro and ex vivo retina angiogenesis assays","volume":"17","author":"Rezzola","year":"2014","journal-title":"Angiogenesis"},{"issue":"8","key":"10.1016\/j.msec.2019.01.036_bb0210","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0014-3057(03)00068-5","article-title":"Synthesis and characterization of water-soluble Osuccinyl-chitosan","volume":"39","author":"Zang","year":"2003","journal-title":"Eur. Polym. J."},{"issue":"20","key":"10.1016\/j.msec.2019.01.036_bb0215","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0142-9612(99)00048-4","article-title":"Self-curing membranes of chitosan\/PAA IPNs obtained by radical polymerization: preparation, characterization and interpolymer complexation","volume":"20","author":"Peniche","year":"1999","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.msec.2019.01.036_bb0220","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00396-011-2437-5","article-title":"Polyelectrolyte complexes of chitosan\/heparin and N,N,N-trimethyl chitosan\/heparin obtained at different pH: I. preparation, characterization, and controlled release of heparin","volume":"289","author":"Martins","year":"2011","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/j.msec.2019.01.036_bb0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijbiomac.2016.02.063","article-title":"Preparation and cytotoxicity of N-modified chitosan nanoparticles applied in curcumin delivery","volume":"87","author":"Facchi","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.msec.2019.01.036_bb0230","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1590\/0104-6632.20160332s20140074","article-title":"Stability improvement of immobilized alkaline phosphatase using chitosan nanoparticles","volume":"33","author":"Jafary","year":"2016","journal-title":"Braz. J. Chem. Eng."},{"issue":"4","key":"10.1016\/j.msec.2019.01.036_bb0235","first-page":"981","article-title":"Vibrational studies of Na2SO4, K2SO4, NaHSO4 and KHSO4 crystals","volume":"2","author":"Periasamy","year":"2009","journal-title":"Rasayan J. Chem."},{"issue":"2","key":"10.1016\/j.msec.2019.01.036_bb0240","first-page":"122","article-title":"Preparation of sodium aluminate from basic aluminium sulfate","volume":"8","author":"Contreras","year":"2006","journal-title":"J. Mater. Process. Adv. Technol."},{"issue":"1","key":"10.1016\/j.msec.2019.01.036_bb0245","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.carbpol.2010.07.057","article-title":"Electrospinning of methoxy poly(ethylene glycol)-grafted chitosan and poly(ethylene oxide) blend aqueous solution","volume":"83","author":"Han","year":"2011","journal-title":"Carbohydr. Polym."},{"issue":"8","key":"10.1016\/j.msec.2019.01.036_bb0250","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1021\/nl0805615","article-title":"Method for analysis of nanoparticle hemolytic properties, in vitro","volume":"8","author":"Dobrovolskaia","year":"2008","journal-title":"Nano Lett."},{"issue":"4","key":"10.1016\/j.msec.2019.01.036_bb0255","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.carbpol.2004.06.033","article-title":"Physicochemical properties and blood compatibility of acylated chitosan nanoparticles","volume":"58","author":"Lee","year":"2004","journal-title":"Carbohydr. Polym."},{"issue":"10","key":"10.1016\/j.msec.2019.01.036_bb0260","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1002\/jbm.a.34591","article-title":"Hematotoxicological analysis of surface-modified and -unmodified chitosan nanoparticles","volume":"101","author":"Nadesh","year":"2013","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"12","key":"10.1016\/j.msec.2019.01.036_bb0265","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s11671-009-9427-2","article-title":"Self-assembled polymeric micellar nanoparticles as nanocarriers for poorly soluble anticancer drug Ethaselen","volume":"4","author":"Li","year":"2009","journal-title":"Nanoscale Res. Lett."},{"issue":"1","key":"10.1016\/j.msec.2019.01.036_bb0270","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0168-3659(87)90034-4","article-title":"A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs","volume":"5","author":"Ritger","year":"1987","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.msec.2019.01.036_bb0275","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0168-3659(87)90035-6","article-title":"A simple equation for description of solute release II. Fickian and anomalous release from swellable devices","volume":"5","author":"Ritger","year":"1987","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.msec.2019.01.036_bb0280","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0378-5173(89)90306-2","article-title":"A simple equation for the description of solute release. III. Coupling of diffusion and relaxation","volume":"57","author":"Peppas","year":"1989","journal-title":"Int. J. Pharm."}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092849311832263X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092849311832263X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T07:17:03Z","timestamp":1606029423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092849311832263X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":56,"alternative-id":["S092849311832263X"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2019.01.036","relation":{},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chitosan grafted-poly(ethylene glycol) methacrylate nanoparticles as carrier for controlled release of bevacizumab","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2019.01.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}